Affordable Access

Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.

Authors
  • Sukasem, C
  • Churdboonchart, V
  • Chasombat, S
  • Kohreanudom, S
  • Watitpun, C
  • Pasomsub, E
  • Piroj, W
  • Tiensuwan, M
  • Chantratita, W
Type
Published Article
Journal
Infection
Publication Date
Apr 01, 2007
Volume
35
Issue
2
Pages
81–88
Identifiers
PMID: 17401711
Source
Medline
License
Unknown

Abstract

With the increased availability of antiretroviral therapy in a resource-constrained country, antiretroviral drug resistance should be closely monitored. HIV-1 drug resistance testing to enable the salvage therapy will remain a priority in Thailand. Furthermore, resistance testing should also become routine before prescribing treatment, and the consequences of continuing to provide a failing regimen must be considered.

Report this publication

Statistics

Seen <100 times